Alas, it just isn’t working out that way. According to an analysis by researchers at Gilead Sciences, Truvada’s manufacturer, only about 1,400 new prescriptions for Truvada were written in 2013. Surprisingly, nearly half of the new users were women.
Why are healthy gay men at risk for HIV infection not rushing to try Truvada? A recent New York Times article describes some of the possibilities, including the drug’s price (about $1,000 per month), inadequate education and marketing, and supposedly even the stigma of being called a “Truvada whore”. Whatever the reason, health officials (and Gilead Sciences) must be disappointed with the fact that new prescriptions represent less than 3% of the annual number of new HIV infections. This drug is not yet reaching the people for whom it is intended…
0 nhận xét Blogger 0 Facebook
Post a Comment
Thank for you